Skip to content

Clinical trials

Phase 2 Glioblastoma trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioblastoma Phase: Phase 2 Country / region: Italy Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20041
20061
20091
20112
20122
20132
20152
20162
20172
20192
20213
20222
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Recruiting5
Terminated3
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC6
Hoffmann-La Roche3
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta2
Novartis Pharmaceuticals2
AbbVie1
Apollomics Inc.1
Bayer1
CNS Pharmaceuticals, Inc.1
Eli Lilly and Company1
Hopital Foch1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioblastoma28
Brain Neoplasms7
Central Nervous System Neoplasms7
Glioma6
Astrocytoma5
Gliosarcoma5
Oligodendroglioma4
Pancreatic Neoplasms2
Stomach Neoplasms2
Biliary Tract Neoplasms1

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.